Cimetidine: a review of the recent developments and reports in cutaneous medicine.
Cimetidine, approved by the FDA for inhibition of gastric acid secretion, has been advocated for a number of dermatological diseases. The cutaneous uses and immunological effects of cimetidine have been actively studied over the past few years, and this review summarizes the literature accumulated since 1997.
Scheinfeld
Noah
N
Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, USA. Scheinfeld@rcn.com
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D002927:Cimetidine / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D004347:Drug Interactions; D012871:Skin Diseases / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D003879:Dermatologic Agents; D002927:Cimetidine